Article
Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations.
Genome research - 20 Nov 2024
Pacholewska Alicja, Lienhard Matthias, Brüggemann Mirko, Hänel Heike, Bilalli Lorina, Königs Anja, Heß Felix, Becker Kerstin, Köhrer Karl, Kaiser Jesko, Gohlke Holger, Gattermann Norbert, Hallek Michael, Herling Carmen D, König Julian, Grimm Christina, Herwig Ralf, Zarnack Kathi, Schweiger Michal R
Abstract excerpt
Mutations in splicing factor 3B subunit 1 (SF3B1) frequently occur in patients with chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDSs). These mutations have different effects on the disease prognosis with beneficial effect in MDS and worse prognosis in CLL patients. A full-length transcriptome approach can expand our knowledge on SF3B1 mutation effects on RNA splicing and its contribution to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
